Breast Cancer Prognosis Raleigh NC

Two new studies have found that levels of the protein caveolin-1 found in stromal connective tissue near a breast cancer tumor can accurately predict a patient's prognosis and may provide a pathway to future treatments in Raleigh.

Ian Christin Horkheimer, MD
(715) 346-5000
4420 Lake Boone Trl
Raleigh, NC
Specialties
Oncology (Cancer)
Gender
Male
Education
Medical School: Univ Of Wi Med Sch, Madison Wi 53706
Graduation Year: 1999

Data Provided by:
Henry L Cromartie III, MD
(919) 782-5660
4420 Lake Boone Trl
Raleigh, NC
Specialties
Oncology (Cancer)
Gender
Male
Education
Medical School: Univ Of Nc At Chapel Hill Sch Of Med, Chapel Hill Nc 27599
Graduation Year: 1979

Data Provided by:
Susan Gibbs Moore
(919) 784-6818
4420 Lake Boone Trl
Raleigh, NC
Specialty
Internal Medicine, Hematology / Oncology

Data Provided by:
Kenneth D Zeitler
(919) 784-6818
4420 Lake Boone Trl
Raleigh, NC
Specialty
Hematology / Oncology, Medical Oncology

Data Provided by:
Dr.Kenneth D Zeitler
(919) 784-6818
4420 Lake Boone Trl
Raleigh, NC
Gender
M
Education
Medical School: Columbia Univ Coll Of Physicians And Surgeons
Year of Graduation: 1975
Speciality
Oncologist
General Information
Accepting New Patients: Yes
RateMD Rating
5.0, out of 5 based on 2, reviews.

Data Provided by:
Sharon Taylor
(919) 620-4467
3404 Wake Forest Rd Ste 202
Raleigh, NC
Specialty
Hematology / Oncology

Data Provided by:
Charles Walter Scarantino
(919) 784-3018
4420 Lake Boone Trl
Raleigh, NC
Specialty
Radiation Oncology

Data Provided by:
Gina Vaccaro
(919) 620-4467
3404 Wake Forest Rd Ste 202
Raleigh, NC
Specialty
Hematology / Oncology

Data Provided by:
Joellen C Speca
(919) 784-6818
4420 Lake Boone Trl
Raleigh, NC
Specialty
Internal Medicine, Hematology / Oncology

Data Provided by:
Elizabeth E Campbell
(919) 781-7070
4101 Macon Pond Rd
Raleigh, NC
Specialty
Internal Medicine, Hematology / Oncology

Data Provided by:
Data Provided by:

Breast Cancer Prognosis

Provided By:

FRIDAY, May 22 (HealthDay News) -- Two new studies have found that levels of the protein caveolin-1 found in stromal connective tissue near a breast cancer tumor can accurately predict a patient's prognosis and may provide a pathway to future treatments.

Low levels of caveolin-1, which plays a role in how cells absorb things, in the stromal cells were linked to a poor patient outcome in a study by Dr. Agnieszka K. Witkiewicz, from Thomas Jefferson University in Philadelphia, and colleagues. The findings are published in the June issue of the American Journal of Pathology.

The second study, in the same issue of the journal, found that a similar lack of stromal caveolin-1 in mice was associated with more aggressive tumor growth in the rodents, according to Erica K. Sloan, from the Peter MacCallum Cancer Centre in East Melbourne, Australia, and colleagues.

The findings led Sloan's research team to hypothesize that caveolin-1 may work as a tumor suppressant, at least in stromal tissue.

"These studies suggest that stromal caveolin-1 expression may be a potential therapeutic target and a valuable prognostic indicator of breast cancer progression," Sloan and colleagues concluded in their report.

Previous research had found that caveolin-1 plays a big part in the development of breast cancer tumors, according to a news release from the journal.

More information

The American Cancer Society has more about breast cancer.

SOURCE: American Journal of Pathology, news release, May 22, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com